How SARS-CoV-2 Omicron spike mutations contribute to increased infectivity SARSCoV2 Omicron SpikeProtein COVID neutralization BA1 BA2 variant evolution cellhostmicrobe uni_ulm TheCrick
By Neha MathurJul 25 2022Reviewed by Benedette Cuffari, M.Sc. In a recent Cell Host and Microbe study, researchers introduce spike mutations found in the severe acute respiratory syndrome coronavirus 2 Omicron variant into the S protein of the SARS-CoV-2 ancestral Wuhan-Hu 1 strain to study the functional impact of these mutations.
Related StoriesOnly about 13% of the SARS-CoV-2 genome encodes for the S protein. Nevertheless, the Omicron S protein contains the greatest number of mutations as compared to other SARS-CoV-2 variants. All current COVID-19 vaccines are based on the SARS-CoV-2 Wuhan-Hu 1 S antigen. As a result, mutations in the NTD or RBD of the Omicron S could increase the resistance of these strains to neutralizing antibodies . These mutations may also be crucial determinants of the higher transmissibility and reduced pathogenicity of these variants.Graphical abstract
The researchers also used full-length S proteins containing a simian virus 5 epitope tag for analysis of Omicron S expression and processing. Several assays were also performed to quantify the number of VSVpp infected Caco-2 cells over time. Mutations in the three serine residues of S371, S373, and S375 severely impaired the ability of the Wuhan Hu-1 S protein to mediate virus-cell and cell-cell fusion. Furthermore, the S371L, S373P, and S375F AA mutated residues promoted interprotomer interactions between the “down” RBDs.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Scientists identify how the coronavirus spike protein causes heart damageNew research has uncovered 'direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells,' according to its lead author.
続きを読む »
SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgASARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA medrxivpreprint vaxart COVID19 Vaccine OralVaccine Trial SARSCoV2
続きを読む »
Scientists identify papain-like protease inhibitor against COVID-19In a new study, researchers identified a papain-like protease inhibitor for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
続きを読む »
NHS staffing crisis: 'I left because it wasn't worth it'Staff who have quit the NHS say pay, pressure and conditions contributed to their decision.
続きを読む »
We've got more clues for the prices of the Galaxy Z Fold 4 and Z Flip 4Small increases on the table
続きを読む »
Is hay fever getting worse in the UK?Experts say that climate change could lengthen hay fever season and increase pollen potency.
続きを読む »